Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Deepika Pakianathan currently holds 13,398 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deepika Pakianathan has been a net buyer of TBPH stock. They have purchased $26.0M and sold $5.6M worth of shares.
Deepika Pakianathan's most recent insider trade was on Jun 12, 2026, when they sold 13,398 shares at $0.00 per share.
Deepika Pakianathan serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 88 insider transactions totaling $31.6M over their tenure at the company.
Deepika Pakianathan holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Deepika Pakianathan has shown a buying trading pattern, with $26.0M in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Deepika Pakianathan was on Jun 8, 2022, when they sold $2.1M worth of KPTI shares. This transaction involved 322,825 shares at $6.50 per share.
Deepika Pakianathan currently owns 13,398 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Deepika Pakianathan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Deepika Pakianathan has 88 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Deepika Pakianathan and 40,000+ other insiders.